Rare diseases
Investigational molecules
Locations
Back to Romania430 clinical trials in Cluj Napoca, Romania across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma
RomaniaStudy on the Effects of Cerebrolysin and Sodium Chloride for Recovery in Patients with Moderate to Severe Traumatic Brain Injury
RomaniaStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
RomaniaStudy on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis
RomaniaStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
RomaniaStudy of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
RomaniaStudy on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli
RomaniaTitle: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727
RomaniaStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
RomaniaStudy on C1 Esterase Inhibitor for Treating and Preventing Hereditary Angioedema Attacks in Patients with C1-INH Deficiency
RomaniaStudy on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer
RomaniaStudy of BI-1206 and Pembrolizumab for Patients with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy
RomaniaThe busiest research cities in the country
What the registry says about research in the country
The clinical trial landscape in Cluj Napoca is strongly centered on oncology and blood cancers, with studies spanning solid tumors and hematologic malignancies. Major efforts focus on improving treatment effectiveness and long-term outcomes for patients with lung cancer, breast cancer, colorectal cancer, lymphoma, and leukemia.
Many of these studies are designed to refine cancer care by comparing newer therapies with standard treatment and by identifying options for harder-to-treat disease subtypes.
There is also a major focus on respiratory medicine, especially chronic and severe lung disease. Research in this area includes trials for COPD, asthma, bronchiectasis, and interstitial lung disease, aiming to improve symptom control and reduce flare-ups.
These trials reflect a strong interest in helping patients breathe more easily and lowering the burden of long-term lung disease.
Clinical trials in cardiology and nephrology are exploring ways to lower the risk of heart, vascular, and kidney complications. In Cluj Napoca, this includes studies in heart failure, atrial fibrillation, hypertension, stroke prevention, and chronic kidney disease.
Several studies are aimed at improving long-term outcomes for patients with overlapping heart and kidney conditions.
Research in digestive diseases and metabolic health is broad, covering inflammatory bowel disease, liver disease, and metabolic dysfunction. Ongoing trials address ulcerative colitis, Crohn’s disease, NASH, hepatitis B, and diabetes, with a clear emphasis on better disease control and organ protection.
These studies highlight a growing interest in treatments that can ease chronic gastrointestinal symptoms while also addressing broader metabolic risk.
A substantial share of research in the city focuses on autoimmune and inflammatory diseases. Trials are studying conditions such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, systemic sclerosis, and Sjögren’s disease, often with the goal of reducing immune-driven damage and improving daily function.
These trials reflect active research into treatments that may better balance immune suppression with safety and long-term benefit.
In neurology and psychiatry, trials are examining both chronic neurological disease and mental health conditions. Key areas include multiple sclerosis, epilepsy, migraine, ADHD, major depressive disorder, and schizophrenia.
In Cluj Napoca, this area combines brain health research with studies of emotional and behavioral well-being.
Skin diseases and allergic disorders are another visible part of the trial portfolio. Research includes atopic dermatitis, alopecia areata, urticaria, bullous pemphigoid, and seasonal allergic rhinitis, with studies designed to ease symptoms and improve skin comfort.
These studies often aim to offer better control for conditions that can be both physically uncomfortable and emotionally burdensome.
The city’s research activity also includes infectious disease and immunology studies. Trials cover COVID-19, hepatitis B, HIV-1 infection, Clostridioides difficile infection, and other immune-related infections, often with the goal of better prevention or treatment support.
These trials show continued attention to both common and complex infectious conditions.
Several trials address endocrine and metabolic disorders, reflecting growing interest in diseases linked to hormones, metabolism, and body weight. Research includes type 2 diabetes, acromegaly, thyroid cancer, obesity, and hypertriglyceridemia.
These projects support a broader effort to improve chronic disease management across metabolism and hormone-related health.
Research in urinary and reproductive health includes both cancer and non-cancer conditions. Trials focus on prostate cancer, bladder cancer, renal cell carcinoma, benign prostatic hyperplasia, and chronic kidney disease, including studies that may improve treatment precision.
These studies are important for patients needing more effective and better-tolerated treatment options.
Cluj Napoca also supports a wide range of specialized studies in rare diseases and complex blood-related conditions. This includes research in hemophilia, myelofibrosis, thrombocytopenia, amyloidosis, and other uncommon disorders that often need targeted approaches.
These trials are especially valuable where treatment choices are limited and specialized expertise is needed.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
